26 minutes ago @Business Wire
New Pivotal Data for Bispecific Antibody Epcoritamab (DuoBody® CD3xCD20) Demonstrates High Overall and Complete Responses in Patients with Hard-To-Treat Relapsed/Refractory Follicular Lymphoma (FL)
|
#ABBV
#percent
#rate
#relapsed
#refractory
#patients
|
26 minutes ago @PRNewsWire
New Data for Bispecific Antibody Epcoritamab (DuoBody® CD3xCD20) Shows Strong, Durable Treatment Response for Patients with Difficult-To-Treat Relapsed/Refractory (R/R) Follicular Lymphoma (FL)
|
#ABBV
#response
#lymphoma
#treated
#patients
#follicular
|
26 minutes ago @GlobeNewsWire
New Pivotal Data for Bispecific Antibody Epcoritamab (DuoBody® CD3xCD20) Demonstrates High Overall and Complete Responses in Patients with Hard-To-Treat Relapsed/Refractory Follicular Lymphoma (FL)
|
#ABBV
#percent
#patients
#lymphoma
#follicular
#response
|
1 day ago @WSJ
$19 Billion in a Week: AbbVie Makes Two Big Bets
|
#ABBV
#seeks
#replace
#neurology
#drugmaker
#doubling
|
1 day ago @Investopedia
AbbVie Buys Cerevel Therapeutics for $8.7B, Bolstering Neuroscience Portfolio
|
#ABBV
#therapeutics
#neuroscience
#cerevel
#abbvie
#jumped
|
1 day ago @InvestorPlace
Healthcare Gems: 3 Essential Long-Term Stock Picks
|
#ABBV
#healthcare
#essential
#term
#pressing
#heart
|
2 days ago @CNBC Television
AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
|
#ABBV
#faber
#therapeutics
#neuroscience
#drugmaker
#david
|
2 days ago @Reuters
Cerevel options trading surge before AbbVie deal news raises eyebrows
|
#ABBV
#cerevel
#abbvie
#surge
#deal
#options
|
2 days ago @InvestorPlace
7 High-Dividend Stocks to Buy for a Lifetime of Passive Income
|
#ABBV
#dividend
#StocksToWatch
#stability
#provide
#dividend
|
2 days ago @Reuters
AbbVie to buy drug developer Cerevel for $8.7 billion
|
#ABBV
#cerevel
#developer
#abbvie
#drug
#billion
|
5 days ago @Seeking Alpha
AbbVie: 4 Hidden Keys Investors Must Know To Judge ImmunoGen Acquisition
|
#ABBV
#abbvie
#acquisition
#immunogen
#keys
#judge
|
6 days ago @Seeking Alpha
Abbott Laboratories: A 'Must-Have' In A Defensive Dividend Growth Portfolio
|
#ABT
#dividend
#abbott
#laboratories
#business
#trailing
|
8 days ago @Proactive Investors
Abbvie's $10bn swoop puts the spotlight on antibody-drug conjugates stocks
|
#ABBV
#abbvie
#drug
#spotlight
#deal
#conjugates
|
9 days ago @Investors Business Daily
AbbVie To Buy ImmunoGen, Cancer Drug Maker, In $10.1 Billion Cash Deal
|
#ABBV
#maker
#immunogen
#abbvie
#cancer
#drug
|
9 days ago @CNBC
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
|
#ABBV
#immunogen
#biotech
#abbvie
#jumped
#drugmaker
|
9 days ago @Investopedia
AbbVie Pays $10.1 Billion for ImmunoGen to Expand Its Cancer Drug Portfolio
|
#ABBV
#expand
#immunogen
#abbvie
#cancer
#portfolio
|
9 days ago @PRNewsWire
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
|
#ABBV
#abbvie
#elahere
#immunogen
#cancer
#ovarian
|
9 days ago @Market Watch
AbbVie $10.1 billion deal to buy ImmunoGen values the stock at a 95% premium
|
#ABBV
#immunogen
#abbvie
#deal
#agreement
#premium
|
9 days ago @Seeking Alpha
AbbVie: Collect Growing Passive Income From This Dividend Aristocrat (Rating Upgrade)
|
#ABBV
#dividend
#dividend
#abbvie
#upgrade
#streak
|
9 days ago @InvestorPlace
Mastering Market Trends: The 7 Best Blue-Chip Stocks for Today's Economy
|
#ABBV
|
12 days ago @Seeking Alpha
Buy 6 December Dividend Kings, 4 More On Watch
|
#ABBV
#dividend
#dividend
#kings
#december
#yields
|
12 days ago @PRNewsWire
AbbVie Announces U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) Updates for Epcoritamab (EPKINLY®/TEPKINLY®) for the Treatment of Relapsed/Refractory Follicular Lymphoma
|
#ABBV
#updates
#medicines
#european
#epcoritamab
#relapsed
|
12 days ago @Market Watch
AbbVie says FDA has granted breakthrough therapy designation to epocritamab for a type of lymphoma
|
#ABBV
#granted
#epocritamab
#designation
#therapy
#lymphoma
|
12 days ago @InvestorPlace
3 Rising Stars: Invest Now in Tomorrow's Trillion-Dollar Companies
|
#ABBV
#dollar
#trillion
#companies
#stars
#standout
|
13 days ago @Seeking Alpha
Abbott Laboratories: One Of The Safest Dividend Growth Stocks On The Market
|
#ABT
#dividend
#laboratories
#healthcare
#abbott
#growth
|
15 days ago @Seeking Alpha
How To Build A Dividend Portfolio Allocating $100,000 Among November's Top 20 Dividend Companies
|
#ABBV
#dividend
#paylimitwall
|
18 days ago @Seeking Alpha
AbbVie Vs. Amgen: How Peter Lynch Picks Dividend Stocks
|
#ABBV
#dividend
#lynch
#amgen
#peter
#dividend
|
18 days ago @GlobeNewsWire
Crinetics Pharmaceuticals to Participate in Upcoming Investor Conferences
|
#CRNX
#Conference
#pharmaceuticals
#crinetics
#participate
#conference
|
20 days ago @24/7 Wall Street
The Best 7 Dividend Stocks to Own in Retirement
|
#ABBV
#dividend
#retirement
#curse
#counting
#blessing
|
21 days ago @Proactive Investors
Weight loss drugs Wegovy and Zepbound to debut in pill form
|
#LLY
#pill
#drugs
#weight
#zepbound
#wegovy
|
21 days ago @InvestorPlace
7 High-Yield Blue Chips Suitable for Any Retiree
|
#ABBV
#dividend
|
29 days ago @Market Watch
Who's afraid of Ozempic? From restaurants to package makers, companies work to calm investors' GLP-1 jitters.
|
#ABT
#ozempic
#widely
#wegovy
#restaurants
#peppered
|
1 month ago @Finbold
15 stocks with the closest US government connections
|
#ABT
#trades
#quiver
#quantitative
#pioneering
#notably
|
1 month ago @Reuters
Abbott India's Q2 profit climbs on strong sales
|
#ABT
#earnings
#abbott
#india
#profit
#sales
|
1 month ago @Seeking Alpha
4 Dividend Aristocrats Signal Buys In November As 6 Await
|
#ABBV
#dividend
#aristocrats
#november
#dividend
#topped
|
1 month ago @Market Watch
Grab these 2 funds with rich 11%-12% yields while you can
|
#ABBV
#paylimitwall
|
1 month ago @InvestorPlace
3 Dividend Stocks That Are Perfect for Beginning Investors
|
#ABBV
#dividend
#dividend
#warranting
#thus
#spark
|
1 month ago @MarketBeat
Guidance leads the market for these stocks; 1 raises, 1 lowers
|
#ABBV
#earnings
#guidance
#earnings
#raising
#lowers
|
1 month ago @InvestorPlace
3 Dividend Kings to Buy for Royal Returns
|
#ABT
#dividend
#kings
#dividend
#supreme
#royal
|
1 month ago @InvestorPlace
Meet the Next Trillion-Dollar Companies: Our Top 3 Picks
|
#ABBV
#nasdaq
#trillion
#meta
#five
#dollar
|
1 month ago @MarketBeat
Investor patience tested as pharmaceutical stocks take a tumble
|
#ABBV
|
1 month ago @PRNewsWire
Abbott and Damar Hamlin Team Up to Build Heart Health Community with New HeartMates Program
|
#ABT
#abbott
#heart
#heartmates
#hamlin
#program
|
1 month ago @Seeking Alpha
Buy 7 November Dividend Kings, Watch 7 More
|
#ABBV
#dividend
#kings
#dividend
#november
#uvv
|
1 month ago @Seeking Alpha
AbbVie Inc. (ABBV) Q3 2023 Earnings Call Transcript
|
#ABBV
#earnings
#CallScript
#president
#chief
#vice
|
1 month ago @Forbes
Is Abbott Stock Undervalued At $95?
|
#ABT
#abbott
#street
#beating
#undervalued
#revenues
|
1 month ago @PRNewsWire
AbbVie Reports Third-Quarter 2023 Financial Results
|
#ABBV
#earnings
#revenues
#percent
#global
#basis
|
1 month ago @Market Watch
AbbVie results beat expectations despite low-cost competition to blockbuster Humira
|
#ABBV
#earnings
#blockbuster
#humira
#abbvie
#expectations
|
1 month ago @Reuters
AbbVie raises profit forecast after Humira, newer drugs drive results beat
|
#ABBV
#earnings
#newer
#drugs
#humira
#abbvie
|
1 month ago @Barrons
AbbVie's Humira Sales Sink 36% but Guidance Lifted on Growth From Other Drugs
|
#ABBV
#abbvie
#guidance
#sink
#lifted
#drugs
|
1 month ago @InvestorPlace
The 7 Best Forever Stocks to Buy for October 2023
|
#ABBV
#StocksToWatch
#forever
#best
#uncertainties
#thunderstorm
|
1 month ago @24/7 Wall Street
Why Dividend Aristocrats Like AbbVie May Be the Best Contrarian Ideas Now
|
#ABBV
#dividend
#ideas
#contrarian
#aristocrats
#abbvie
|
1 month ago @MarketBeat
The Value Deepens for Medtech Stocks: Reversal Imminent
|
#ABT
#medtech
#johnson
#nyse
#imminent
#foreshadow
|
1 month ago @Business Wire
Alzamend Neuro Submits IND Application for a Phase IIA Clinical Trial in Major Depressive Disorder Patients of its Next‑Generation Lithium Therapeutic Drug Candidate AL001
|
#ABBV
#trial
#therapeutic
#neuro
#iia
#disorder
|
1 month ago @Seeking Alpha
Abbott Labs: Fear Is In The Air - That's Why I'm Bullish
|
#ABT
#abbott
#portfolio
#segments
#grew
#fear
|
1 month ago @Reuters
Medical device makers see limited hit from weight-loss drugs
|
#ABT
#makers
#drugs
#weight
#medical
#device
|
1 month ago @InvestorPlace
7 Dividend Stocks to Buy and Hold Forever and Ever
|
#ABBV
#dividend
#StocksToWatch
#dividend
#searching
#flooded
|
1 month ago @InvestorPlace
7 Blue-Chip Stocks to Buy on the Dip
|
#ABT
#StocksToWatch
#blue
#chip
#straightforward
#stalwarts
|
1 month ago @Barrons
Abbott Earnings Show Obesity Drug Worries Are Overblown
|
#ABT
#earnings
#obesity
#worries
#robert
#overblown
|
1 month ago @CNBC Television
'We don't see' weight-loss drugs impacting medical devices' sales, says Abbott CEO Robert Ford
|
#ABT
#weight
#ford
#drugs
#abbott
#robert
|
1 month ago @Seeking Alpha
Abbott Laboratories (ABT) Q3 2023 Earnings Call Transcript
|
#ABT
#earnings
#CallScript
#abbott
#laboratories
#call
|
1 month ago @PRNewsWire
Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range
|
#ABT
#earnings
#sales
#abbott
#base
#percent
|
1 month ago @Reuters
Abbott beats profit estimates on strong sales of devices, diagnostics
|
#ABT
#earnings
#diagnostics
#devices
#abbott
#estimates
|
1 month ago @Market Watch
Abbott Labs shares rise as company beats earnings estimates, raises full-year guidance
|
#ABT
#earnings
#cents
#guidance
#abbott
#billion
|
1 month ago @Forbes
Which Is A Better Pick – Abbott Stock Or Amgen?
|
#ABT
#better
#three
#sections
#pick
#amgn
|
1 month ago @PRNewsWire
AbbVie's SKYRIZI® (risankizumab) Versus STELARA® (ustekinumab) Head-to-Head Study in Crohn's Disease Meets All Primary and Secondary Endpoints
|
#ABBV
#risankizumab
#week
#head
#ustekinumab
#crohn
|
1 month ago @InvestorPlace
7 Dividend Kings to Buy for Royal Returns
|
#ABBV
#dividend
#dividend
#kings
#stockholders
#shareholders
|
1 month ago @PRNewsWire
AbbVie Announces Upadacitinib (RINVOQ®) Met the Primary Endpoint in Phase 2 Clinical Trial of Vitiligo as Program Advances to Phase 3
|
#ABBV
#upadacitinib
#vitiligo
#vasi
#percent
#baseline
|
2 months ago @CNBC
As Covid testing business drops, Abbott searches for new line of business with consumer wearables
|
#ABT
#product
#abbott
#business
#wearables
#wearable
|
2 months ago @InvestorPlace
Retirement Royalty: 3 Dividend Aristocrats for a Steady Income Stream
|
#ABBV
#dividend
#dividend
#income
#investing
#royalty
|
2 months ago @PRNewsWire
AbbVie Exercises Exclusive Right to Acquire Mitokinin, Further Strengthening Neuroscience Pipeline
|
#ABBV
#mitokinin
#mitochondrial
#disease
#parkinson
#exclusive
|
2 months ago @InvestorPlace
7 Top Healthcare Stocks That Pay Dividends
|
#ABBV
#dividend
#healthcare
#dividends
#pay
#uncertain
|
2 months ago @PRNewsWire
AbbVie to Host Third-Quarter 2023 Earnings Conference Call
|
#ABBV
#earnings
#Conference
#abbvie
#third
#quarter
|
2 months ago @Business Wire
Alzamend Neuro Receives FDA “Study May Proceed” Notification for a Phase IIA Clinical Trial of AL001, a Next-Generation Lithium Therapeutic Drug Candidate, in Bipolar Disorder Patients
|
#ABBV
#receives
#proceed
#neuro
#disorder
#bipolar
|
2 months ago @InvestorPlace
Moonshot Medicine: 3 Stocks to Buy to Bet on Long-Shot Drugs
|
#ABBV
#StocksToWatch
#drugs
#trials
#standards
#moonshot
|
2 months ago @Seeking Alpha
Abbott Laboratories Triumphs Over Challenges: A Tale Of Resilience
|
#ABT
#nathan-aisenstadt
#investing-ideas
#long-ideas
#deep-value
#isrg
|
2 months ago @PRNewsWire
AbbVie Presents Results from Phase 3 CANOVA Study of Venetoclax in Patients with Relapsed or Refractory Multiple Myeloma
|
#ABBV
#myeloma
#venetoclax
#multiple
#dexamethasone
#canova
|
2 months ago @Reuters
AbbVie's blood cancer combo therapy fails in late-stage study
|
#ABBV
#cancer
#blood
#therapy
#abbvie
#study
|
2 months ago @Investors Business Daily
Why Abbott Says It Won't Be A Casualty Of The Weight-Loss Battle
|
#ABT
#weight
#abbott
#loss
#drugs
#diabetes
|
2 months ago @CNBC Television
Final Trades: Abbott Labs, Yields & more
|
#ABT
#yields
#labs
#halftime
#picks
#abbott
|
2 months ago @InvestorPlace
Don't Miss the Boom: 3 Biotech Stocks Set to Explode Higher
|
#ABBV
#biotech
#realm
#drugs
#rewards
#ready
|
2 months ago @MarketBeat
2 Stocks to Benefit from the Aging Population
|
#ABT
#aging
#population
#wellness
#unpredictable
#predictable
|
2 months ago @PRNewsWire
AbbVie Announces European Commission Approval of TEPKINLY® (epcoritamab) for Adults with Relapsed or Refractory Diffuse Large B-cell Lymphoma
|
#ABBV
#tepkinly
#european
#relapsed
#refractory
#lymphoma
|
2 months ago @Fox Business
Abbott India warns of potential laxative syrup shortages amid production halt
|
#ABT
#shortages
#laxative
#india
#halt
#abbott
|
2 months ago @Reuters
AbbVie terminates deal with I-Mab to develop cancer drug
|
#ABBV
#cancer
#abbvie
#drug
#develop
#deal
|
2 months ago @Business Wire
Alzamend Neuro Granted Extension by Nasdaq Panel to Regain Compliance with the Minimum Bid Price Continued Listing Requirement
|
#ABBV
#alzamend
#requirement
#regain
#panel
#neuro
|
2 months ago @PRNewsWire
Abbott Declares 399th Consecutive Quarterly Dividend
|
#ABT
#dividend
#abbott
#quarterly
#dividend
#prnewswire
|
2 months ago @InvestorPlace
The 7 Most Hated Stocks by Institutional Traders
|
#LLY
#institutional
#traders
#snapping
#rollercoaster
#keen
|
2 months ago @Investors Business Daily
Drug Giant Eli Lilly Hits Profit Zone Amid Enthusiasm For Weight-Loss Drugs
|
#LLY
#lilly
#giant
#enthusiasm
#drugs
#drug
|
2 months ago @Seeking Alpha
Abbott Laboratories: Buy This Fairly Valued Dividend King For Consistently Rising Income
|
#ABT
#kody-s-dividends
#investing-ideas
#long-ideas
#sa-exclusive
#quality-multiplier
|